Use of isoxazolin-3-one derivatives as antidepressants

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142368, 5142255, 5142265, 5142315, 514254, 5142338, 5142355, 5142375, 514378, 514380, 514408, 514414, A61K 31535, A61K 3140, A61K 3142, A61K 3154

Patent

active

052179702

ABSTRACT:
A method of treating depression comprising administering to a patient an effective antidepressive amount of a compound of the formula ##STR1## wherein either (i) the endocyclic dotted line ( ) is a double bond; the exoxyclic dotted line ( ) is a single bond;

REFERENCES:
patent: 4505921 (1985-03-01), Beregi et al.
patent: 4579860 (1986-04-01), Tomita et al.
patent: 4849441 (1989-07-01), Okazaki et al.
patent: 4863948 (1989-09-01), Arrowsmith et al.
Patent Abstracts of Japan, vol. 12, No. 467 (C-550) [3314], Dec. 7, 1988 of JP-A-63-188625 (Mitsui Toatsu Chem. Inc.) Apr. 8, 1988, Japan.
Patent Abstracts of Japan, vol. 5, No. 89 (C-58) [761], Jun. 1981 of JP-A-5634674 (Sankyo K.K.), 6-4-1081; Japan.
Patent Abstracts of Japan, vol. 6, No. 90 (C-104)[1968], May 27, 1982 of JP-1-5721377 (Shinogi Seiyaku K.K.) Apr. 2, 1982; Japan.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of isoxazolin-3-one derivatives as antidepressants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of isoxazolin-3-one derivatives as antidepressants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of isoxazolin-3-one derivatives as antidepressants will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1934216

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.